Assessment of early treatment results with antineoplaston AS2-1 in subacute sclerosing panencephalitis;Ocena bezpośrednich (wczesnych) wyników leczenia antyneoplastonem AS2-1 u chorych z podostrym stwardniajacym zapaleniem mózgu (SSPE).

Neurologia i neurochirurgia polska

Volumn 31, Issue 6, 1997, Pages 1147-1156

  Sobczyk, W ^a   Pilkowska E ^a   Iwinska Buksowicz B ^a   Jakubowska, T ^a  

^a Kliniki Neurologicznej IPiN w Warszawie ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTON AS2-1; ANTIVIRUS AGENT; DRUG DERIVATIVE; GLUTAMINE; METHISOPRINOL; PHENYLACETIC ACID DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; FEMALE; HUMAN; MALE; SUBACUTE SCLEROSING PANENCEPHALITIS; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GLUTAMINE; HUMANS; INOSINE PRANOBEX; MALE; PHENYLACETATES; SUBACUTE SCLEROSING PANENCEPHALITIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031267817     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)